文献
J-GLOBAL ID:202102283979126587
整理番号:21A0079283
Nek2阻害剤としての新規イミダゾ[1,2-a]ピリジン誘導体の設計,合成および構造活性相関(SAR)研究【JST・京大機械翻訳】
Design, synthesis, and structure activity relationship (SAR) studies of novel imidazo[1,2-a] pyridine derivatives as Nek2 inhibitors
著者 (14件):
Wang Haili
(Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China)
,
Chen Yunzhong
(Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China)
,
Gu Xiaofan
(Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China)
,
Xi Jianbei
(Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China)
,
Ren Ziwei
(Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China)
,
Wang Shuting
(Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China)
,
Duan Yanhong
(Key Laboratory of Brain Functional Genomics-Ministry of Education, School of Life Science, East China Normal University, 3663 North Zhongshan Road, Shanghai, China)
,
Li Hongyu
(Department of Pharmaceutical Science, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA)
,
Zhu Tong
(Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China)
,
Du Yijie
(Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China)
,
Du Yijie
(Institutes of Integrative Medicine, Fudan University, Shanghai 200040, China)
,
Zhang Xiongwen
(Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China)
,
Ma Mingliang
(Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, College of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China)
,
Ma Mingliang
(Key Laboratory of Brain Functional Genomics-Ministry of Education, School of Life Science, East China Normal University, 3663 North Zhongshan Road, Shanghai, China)
資料名:
Bioorganic & Medicinal Chemistry
(Bioorganic & Medicinal Chemistry)
巻:
28
号:
23
ページ:
Null
発行年:
2020年
JST資料番号:
W0556A
ISSN:
0968-0896
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)